Chronotropic Effect of the Antithrombotic Agent Cilostazol in a Patient with Sick Sinus Syndrome and Syncope

By Moriya J   Takahashi T   Nomura Y   Kawaura K   Kusaka K   Yamakawa J   Fujioka N   Okubo S   Itoh T   Kanda T  

The Journal of International Medical Research, Vol. 32, Iss. 5, 2004-09 ,pp. : 549-551

Field House Publishing

Access to resources Recommend Favorite

Cilostazol

By Sorkin E.M.   Markham A.  

Drugs & Aging, Vol. 14, Iss. 1, 1999-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite

Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent

By Walenga Jeanine M   Jeske Walter P   Frapaise F Xavier   Bick Rodger L   Fareed Jawed   Samama M Michel  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 3, 2002-03 ,pp. : 397-407

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet and Antithrombotic Activity of Cilostazol is Potentiated by Dipyridamole in Rabbits and Dissociated from Bleeding Time Prolongation

By Li Haiquan   Cone James   Fong Miranda   Kambayashi Junichi   Yoshitake Masuhiro   Liu Yongge  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 41-48

Springer Publishing Company

Access to resources Recommend Favorite

Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats

By Yamamoto Y.   Yasuda Y.   Kimura Y.   Yoshiaki Komiya  

European Journal of Pharmacology, Vol. 352, Iss. 2, 1998-07 ,pp. : 171-178

Elsevier

Access to resources Recommend Favorite